All use cases

Prepare a batch for review.

Ask neil to check execution, LIMS and quality evidence against your batch-review requirements. Get a source-linked brief, missing-evidence requests and a clear account of what changes when new records arrive.

Book a demo
Illustration of a seal beside an open evidence folio containing SOP, training and execution records.

You: Can you get B-2407 ready for QA review?

neil

Yes. I found a few gaps to sort out first.

The packaging-stop assessment is still open, and two QC reports aren’t attached. I’ll bring those into the review brief with the sources behind each finding.

See the five sources

This example uses selected execution, LIMS, quality and ERP snapshots, plus a controlled review-plan excerpt. In your environment, these can come from configured connections or supplied exports.

Example records; no live query or source changes.

You: But the batch is marked complete?

neil

That’s the execution status, not a QA decision.

still shows a quality hold, and no QA disposition is recorded. I can prepare the review; I won’t change the stock status.

You: The assay passed. What’s missing?

neil

The supplied plan names three reports. I have one.

The assay result and method match . I’d ask QC for the other two reports and their review status.

Missing from this package doesn’t mean the tests failed—or weren’t run.

You: Put that in a brief for Quality. Include who needs to follow up.

neil

Here’s the draft. Each finding has its source version and a follow-up for QC, Quality or the batch reviewer.

B-2407 review brief · Draft 01Findings, source versions and follow-up work
B-2407Draft 01

Batch review brief

Execution is complete. Three review items need attention.

Pending in v03

Product-impact assessment

DEV-038 does not yet establish the product impact of the packaging interruption.

Two reports not supplied

Complete QC panel

QC-2407 supplies assay. BR-012 also requires dissolution and related substances. Missing from this package does not mean the tests were not performed.

Not recorded

QA disposition

B-2407 has no QA signature. STOCK-2407 remains a 09:00 quality-hold snapshot; no live release status has been checked.

Review basis and selected versions

Checked against the supplied BR-012 v06 excerpt. This brief is not an exhaustive batch-release checklist.

Selected snapshots: 9 September 2026, 09:00 UTC. Original source versions stay attached to this brief.

Follow-up work by owner
QC reviewer
Supply the dissolution and related-substances reports for B-2407. Confirm sample and batch identity, applicable methods and specifications, report review status and any exceptions.
Deviation owner
Complete the product-impact assessment in DEV-038 using the line-stop log, segregated-unit reconciliation and independent restart check; route it to the authorised reviewer.
QA reviewer
Confirm the complete batch-review scope and assess the execution, analytical and deviation evidence. Refresh source statuses before recording any disposition; preserve required signatures and the stock restriction until the authorised process permits a change.

Send me the updated assessment when it arrives and I can refresh the brief.

This demo uses prewritten replies.

Bring the batch that’s waiting for review.

Give neil the batch reference and your review requirements. Connect the relevant systems or supply the records. Get a brief with source versions, missing evidence and follow-up work your reviewers can act on.

Book a demo
Execution system / v07

B-2407

Batch execution record

Batch
B-2407
Product
T-24 tablets / 100 mg
Execution
Complete
QC evidence
QC-2407 attached
Linked deviation
DEV-038
QA signature
Not recorded
Snapshot
9 September 2026, 09:00 UTC

Execution completion is the recorded workflow state, not a completed QA review. The underlying execution evidence and applicable review requirements still need verification.

Browse all use cases